To define the circulating miRNA response to endotoxemia without common confounders such as medication and co-morbidities in critically-ill sepsis patients, we employed an experimental low-dose endotoxemia model in combination with P2Y12 inhibitor treatment in healthy volunteers. Here, P2RY12 is linked to serum lipopolysaccharide activity.